Company: BDRX
Filing Date: 2025-05-08
Form Type: POS AM
Source: 0001214659-25-007201
Chunk: 127

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-05-08
Form: POS AM
Chunk 127
---
 signed by the following persons in the capacities and on the date indicated.

| Name and Signature    
 /s/ Stephen Stamp     |     | Title(s)                                                                                  
 Chief Executive Officer, Director,                                                        |     | Date        
 May 8, 2025 |
|:----------------------|:----|:------------------------------------------------------------------------------------------|:----|:------------|
| Stephen Stamp         |     | Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer |     |             |
| *                     |     | Non-Executive Chairman of the Board                                                       |     | May 8, 2025 |
| Stephen Parker        |     |                                                                                           |     |             |
| *                     |     | Senior Independent Non-Executive Director                                                 |     | May 8, 2025 |
| Simon Turton, Ph.D.   |     |                                                                                           |     |             |
|                       |     | Non-Executive Director                                                                    |     |             |
| Sijmen de Vries, M.D. |     |                                                                                           |     |             |
| *                     |     | Non-Executive Director                                                                    |     | May 8, 2025 |
| Ann Merchant          |     |                                                                                           |     |             |

| *By: | /s/ Stephen Stamp |
|      | Stephen Stamp     |
|      | Attorney-in-fact  |

| II-4 |

<div align='center'>AUTHORIZED REPRESENTATIVE</div>

Pursuant to the requirements of the Securities Act of 1933,
as amended, this Registration Statement on Form F-1 has been signed by the undersigned on this 8th day of May, 2025.

| By:    | /s/ Donald J. Puglisi                          |
| Name:  | Donald J. Puglisi                              |
| Title: | Authorized Representative in the United States |

| II-5 |

<div align='center'>Exhibit Index</div>

| Exhibit 
 Number  
 3.1     
 4.1     | Title                                                                                                                                                                                                                                                                                                                                                                                         
 Articles of Association of Biodexa Pharmaceuticals PLC, adopted on November 22, 2024 (incorporated by reference to Exhibit 1.1 to the Company’s Report on Form 6-K, filed with the SEC on December 27, 2024).                                                                                                                                                                                 
 Description of Securities Registered Under Section 12 of the Exchange Act (incorporated by reference to Exhibit 2.1 to the Company’s Annual Report on Form 20-F,